The iTRAQ-based proteomic analysis performed in this study identifies apoC-II and apoC-III that are related to BP abnormalities, showing that both are associated with several surrogate markers of CV risk in a pediatric CKD population. The gene discussed is APOC2; the disease is chronic kidney disease.